MedTrace Logo

Behavioral Science Aspects of Rapid Test Acceptance

NCT01317784 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2015-07-29

No results posted yet for this study

Summary

The relevance of this research to public health is to make it possible to test for hepatitis C and syphilis at point of care so that people will receive their results immediately instead of requiring people to wait for at least a week to get their test results. This research will make rapid tests for HIV available that can detect HIV infection earlier and are more accurate than current tests available in the United States.

Conditions

Interventions

DEVICE

Rapid tests for HIV, HCV, HBV, and syphilis

Choice of 16 different rapid tests. Only 12 manufacturer and names are shown because some are used with both blood and oral fluid. When they are used on both specimens, they are counted as two tests.

DEVICE

HIV/HCV

Choice of 10 different tests for HIV and hepatitis C.

DEVICE

HIV/syphilis

Choice of 7 different tests for HIV and syphilis

DEVICE

HIV only

Choice of 4 different tests for HIV only.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • California State University, Long Beach

    lead OTHER

Principal Investigators

  • Dennis G Fisher, Ph.D. · California State University, Long Beach

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-06-30
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01317784 on ClinicalTrials.gov